Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Satellos Bioscience Inc
T.MSCL
Alternate Symbol(s):
MSCLF
Healthcare
Biotechnology
Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and...
regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MSCL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(12)
•••
Helpmepleaseeee
X
View Profile
View Bullboard History
Post by
Helpmepleaseeee
on Sep 09, 2021 6:29pm
Shares
No one listen to this T@@L!!! The split is don't. The iCo shares we once had are now one with Satellos. We are one. Our share price will be going through the roof soon enough. Just be
...more
(418)
•••
beenthere
X
View Profile
View Bullboard History
Comment by
beenthere
on Sep 09, 2021 3:56pm
RE:RE:RE:160,000 Shares Equals 1 Percent
I agree. Just SH that's all. Doesn't matter what the ratio was. ICO no longer exists period. This company is now Satellos Bioscience Inc. and SH should show it as such! Maybe time for
...more
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project
posted May 01, 2024 9:00am by
Viva Gold Corp.
-
|
Previously unknown areas of gold mineralization were discovered with longer lengths and higher gold grades than expected. 21.3 meters at 5.1 gpt Au was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40-meters depth). James Hesketh, President & CEO stated, “Many geologists go their whole careers without seeing drill results like these ...read more
(31)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Sep 09, 2021 12:11pm
RE:RE:RE:160,000 Shares Equals 1 Percent
We need the volume to be over 100K
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 09, 2021 8:45am
RE:RE:160,000 Shares Equals 1 Percent
We are now one entity. The exchange ratio was 20 ICO for 1 MSCL. Now I think it's about time Stockhouse label this BB properly as Satellos Biosciences Inc. and not ICO Therapeutics. GLTA G1945V
(418)
•••
beenthere
X
View Profile
View Bullboard History
Comment by
beenthere
on Sep 05, 2021 9:47am
RE:160,000 Shares Equals 1 Percent
Blinkie, we just did the reverse takeover. There has been no changes in the share structure since then. We (former ICO shareholders) own 27.7% of MSCL.. That amounts to 9 064 636 shares not 16
...more
(23)
•••
blinkie
X
View Profile
View Bullboard History
Post by
blinkie
on Sep 03, 2021 7:11pm
160,000 Shares Equals 1 Percent
Stellios not selling but maybe buying 16 million shares are owned bi Ico shareholders. dpnt sell.
(31)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Sep 03, 2021 11:19am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Very nice stock
Trading it again today. So far the MM is allowing it.
(31)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Sep 02, 2021 7:02pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Very nice stock
(31)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Aug 31, 2021 1:04pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Very nice stock
Out with that one as well. My last one is at 1.69, partially out right now.
(31)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Aug 31, 2021 11:28am
RE:RE:RE:RE:RE:RE:RE:RE:Very nice stock
Out with that one as well, third one is at 1.67
(31)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Aug 31, 2021 10:32am
RE:RE:RE:RE:RE:RE:RE:Very nice stock
One lot out at 1.58 and one lot partial out at 1.63
(31)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Aug 30, 2021 4:48pm
RE:RE:RE:RE:RE:RE:Very nice stock
Back in at $1.52. Average price now at $1.73
(31)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Aug 27, 2021 6:13pm
RE:RE:RE:RE:RE:Very nice stock
If there was 5-6 players like me we would be at $2.10 already. The MM is waiting.
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Aug 27, 2021 6:04pm
RE:RE:RE:RE:Very nice stock
thanks for the play by play
(31)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Aug 27, 2021 4:04pm
RE:RE:RE:Very nice stock
Back in at 1.53 and 1.58, my average is now 1.81.
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company